Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery

British Journal of Anaesthesia

Volumn 99, Issue 2, 2007, Pages 252-261

  Rigby Jones, A E ^a   Priston, M J ^b   Sneyd, J Robert ^a   McCabe, A P ^c   Davis, G I ^c   Tooley, M A ^d   Thorne, G C ^d   Wolf, A R ^c,e  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^d UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Analgesics opioid, remifentanil; Children; Hypnotics benzodiazepines, midazolam; Pharmacokinetics remifentanil; Sedation

Indexed keywords

ADRENALIN; DIAZEPAM; DOPAMINE; FENTANYL; ISOFLURANE; MIDAZOLAM; MILRINONE; MORPHINE; NITROPRUSSIDE SODIUM; NORADRENALIN; PANCURONIUM; REMIFENTANIL;

AGE DISTRIBUTION; ALLOMETRY; ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INFUSION; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; HEART SURGERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTENSION; INFANT; INFUSION RATE; MAINTENANCE DRUG DOSE; MALE; PATIENT SATISFACTION; PEDIATRIC ANESTHESIA; POPULATION MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SIDE EFFECT; WAKEFULNESS;

EID: 34547857015     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem135     Document Type: Article

References (31)

1. Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 2000; 28: 2122-32
2. Webster NR. Opioids and the immune system. Br J Anaesth 1998; 81; 835-6
3. Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Crit Care Med 1999; 27: 32-3
4. Shelly MP, Sultan MA, Bodenham A, Park GR. Midazolam infusions in critically ill patients. Eur J Anaesthesiol 1991; 8: 21-7
5. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8: 491-9
6. Cray SH, Robinson BH, Cox PN. Lactic academia and bradycardia in a child sedated with propofol. Crit Care Med 1998; 26: 2087-92
7. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996, 84: 821-33
8. Akinci SB, Kanbak M, Guler A, Aypar U. Remifentanil versus fentanyl for short-term analgesia-based sedation in mechanically ventilated postoperative children. Paediatr Anaesth 2005; 15: 870-8
9. Antmen B, Sasmaz I, Birbicer H, et al. Safe and effective sedation and analgesia for bone marrow aspiration procedures in children with alfentanil, remifentanil and combinations with midazolam. Paediatr Anaesth 2005; 15: 214-9
10. Dahaba AA, Grabner T, Rehak PH, List WF, Metler H. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: A randomized double blind study. Anesthesiology 2004; 101: 640-6
11. Davis PJ, Wilson AS, Siewers RD, Pigula FA, Landsman IS. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg 1999; 89: 904-8
12. Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analyis: Concepts and Applications, 2nd Edn. Stockholm: The Swedish Pharmaceutical Press, 1997; 311-7
13. Selinger K, Lanzo C, Sekut A. Determination of remifentanil in human and dog blood by HPLC with UV detection. J Pharm Biomed Anal 1994; 12: 243-8
14. Ambuel B, Hamlett KW, Marx CM, Blumer JL. Assessing distress in pediatric intensive care environments: The COMFORT scale. J Pediatr Psychol 1992; 17: 95-109
15. Wright PM. Population based pharmacokinetic analysis: Why do we need it; what is it; and what has it told us about anaesthetics? Br J Anaesth 1998; 80: 488-501
16. Boeckmann AJ, Beal SL, Sheiner LB. NONMEM Users Guide. San Francisco, CA: University of California-San Francisco, 1999
17. Jonsson EN, Karlsson MO. Xpose-an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 1999; 58: 51-64
18. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997, 276: 122-6
19. Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992; 20: 63-94
20. Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 1999; 59: 19-29
21. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10-23
22. Rigby-Jones AE, Nolan JA, Priston MJ, Wright PM, Sneyd JR. Wolf AR. Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002; 97: 1393-400
23. Murray DM, Thorne GC, Rigby-Jones AE, et al. Electro-encephalograph variables, drug concentrations and sedation scores in children emerging from propofol infusion anaesthesia. Paediatr Anaesth 2004; 14: 143-51
24. Veselis RA, Reinsel RA, Feshchenkio VA, Wronski M. The comparative amnestic effects of midazolam, propofol, thiopental and fentanyl at equisedative concentrations. Anesthesiology 1997; 87: 749-64
25. Bauman LA, Cannon ML, McCloskey J, et al. Unconscious sedation in children: A prospective multi-arm clinical trial. Paediatr Anaesth 2002; 12: 674-9
26. Donmez A, Kizilkan A, Berksun H, Varan B, Tokel K. One center's experience with remifentanil infusions for pediatric cardiac catheterization. J Cardiothorac Vasc Anesth 2001; 15: 736-9
27. Stoppa F, Perrotta D, Tomasello C. et al. Low dose remifentanyl infusion for analgesia and sedation in ventilated newborns. Minerva Anestesiol 2004; 70: 753-61
28. Ross AK, Davis PJ, del Dear GL, et al. Pharmacokinetics of remifentanil in anesthetized paediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg 2001; 93: 1393-401
29. Koren G, Goresky G, Crean P, Klein J, MacLeod SM. Unexpected alterations in fentanyl pharmacokinetics in children undergoing cardiac surgery: Age related or disease related? Dev Pharmacol Ther 1986; 9: 183-91
30. Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J Pharmacol Exp Ther 1997; 281: 226-32
31. Breen D, Wilmer A, Bodenham A, et al. Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care 2004; 8: R21-30